T 1818/18 (Dry powder inhalation drug products / GLAXOSMITHKLINE) of 07.10.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T181818.20211007
- Date of decision
- 7 October 2021
- Case number
- T 1818/18
- Online on
- 4 January 2022
- Petition for review of
- -
- Application number
- 11755043.4
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- DRY POWDER INHALATION DRUG PRODUCTS EXHIBITING MOISTURE CONTROL PROPERTIES AND METHODS OF ADMINISTERING THE SAME
- Applicant name
- GlaxoSmithKline Intellectual Property Development Limited
- Opponent name
- Oser, Andreas
Generics (U.K.) Limited
Teva UK Limited - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention R 111(2)European Patent Convention Art 114(2)Rules of procedure of the Boards of Appeal Art 12(4)Rules of procedure of the Boards of Appeal 2020 Art 011Rules of procedure of the Boards of Appeal 2020 Art 013(1)European Patent Convention Art 54(3)European Patent Convention Art 56European Patent Convention Art 83
- Keywords
- Substantial procedural violation - appealed decision reasoned (yes)
Late submitted material - admitted (partly)
Sufficiency of disclosure - (yes)
Novelty - (yes)
Inventive step - (yes) - Catchword
- -
- Cited cases
- G 0001/15
- Citing cases
- -
Order
For these reasons it is decided that:
The appeals are dismissed.